FDA / 2025
EGRIFTA WR prescribing information
EGRIFTA WR prescribing information — U.S. FDA (2025), cited in PeptideAgent's Tesamorelin evidence record.
Open original sourceSOURCE METADATA
What this record represents.
- Publisher
- U.S. FDA
- Evidence type
- FDA
- Publication year
- 2025
- Source ID
- fda-egrifta-label
WHERE THIS IS CITED